197 related articles for article (PubMed ID: 19357976)
1. Analysis of PPARalpha-dependent and PPARalpha-independent transcript regulation following fenofibrate treatment of human endothelial cells.
Araki H; Tamada Y; Imoto S; Dunmore B; Sanders D; Humphrey S; Nagasaki M; Doi A; Nakanishi Y; Yasuda K; Tomiyasu Y; Tashiro K; Print C; Charnock-Jones DS; Kuhara S; Miyano S
Angiogenesis; 2009; 12(3):221-9. PubMed ID: 19357976
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate regulates retinal endothelial cell survival through the AMPK signal transduction pathway.
Kim J; Ahn JH; Kim JH; Yu YS; Kim HS; Ha J; Shinn SH; Oh YS
Exp Eye Res; 2007 May; 84(5):886-93. PubMed ID: 17343853
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt.
Grabacka M; Plonka PM; Urbanska K; Reiss K
Clin Cancer Res; 2006 May; 12(10):3028-36. PubMed ID: 16707598
[TBL] [Abstract][Full Text] [Related]
4. PPARalpha activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway.
Ji YY; Liu JT; Liu N; Wang ZD; Liu CH
Biochem Pharmacol; 2009 Nov; 78(9):1186-97. PubMed ID: 19576184
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1.
Grau R; Punzón C; Fresno M; Iñiguez MA
Biochem J; 2006 Apr; 395(1):81-8. PubMed ID: 16343055
[TBL] [Abstract][Full Text] [Related]
6. PPARalpha activators upregulate eNOS activity and inhibit cytokine-induced NF-kappaB activation through AMP-activated protein kinase activation.
Okayasu T; Tomizawa A; Suzuki K; Manaka K; Hattori Y
Life Sci; 2008 Apr; 82(15-16):884-91. PubMed ID: 18346759
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the actions of peroxisome proliferator-activated receptor alpha on obesity by estrogen.
Jeong S; Yoon M
Obesity (Silver Spring); 2007 Jun; 15(6):1430-40. PubMed ID: 17557980
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells.
Goya K; Sumitani S; Xu X; Kitamura T; Yamamoto H; Kurebayashi S; Saito H; Kouhara H; Kasayama S; Kawase I
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):658-63. PubMed ID: 14751809
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor alpha-independent peroxisome proliferation.
Zhang X; Tanaka N; Nakajima T; Kamijo Y; Gonzalez FJ; Aoyama T
Biochem Biophys Res Commun; 2006 Aug; 346(4):1307-11. PubMed ID: 16806075
[TBL] [Abstract][Full Text] [Related]
10. The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.
Stienstra R; Mandard S; Tan NS; Wahli W; Trautwein C; Richardson TA; Lichtenauer-Kaligis E; Kersten S; Müller M
J Hepatol; 2007 May; 46(5):869-77. PubMed ID: 17321000
[TBL] [Abstract][Full Text] [Related]
11. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.
Lee GY; Kim NH; Zhao ZS; Cha BS; Kim YS
Biochem J; 2004 Mar; 378(Pt 3):983-90. PubMed ID: 14641110
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors.
Ichihara S; Obata K; Yamada Y; Nagata K; Noda A; Ichihara G; Yamada A; Kato T; Izawa H; Murohara T; Yokota M
J Mol Cell Cardiol; 2006 Aug; 41(2):318-29. PubMed ID: 16806263
[TBL] [Abstract][Full Text] [Related]
13. Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator- activated receptor alpha agonists.
Yamazaki K; Kuromitsu J; Tanaka I
Biochem Biophys Res Commun; 2002 Jan; 290(3):1114-22. PubMed ID: 11798191
[TBL] [Abstract][Full Text] [Related]
14. Effect of peroxisome proliferator-activated receptor alpha on human angiotensinogen promoter.
Shimamoto Y; Hirota K; Fukamizu A
Int J Mol Med; 2004 May; 13(5):729-33. PubMed ID: 15067378
[TBL] [Abstract][Full Text] [Related]
15. Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells.
Dragomir E; Tircol M; Manduteanu I; Voinea M; Simionescu M
Vascul Pharmacol; 2006 Jun; 44(6):440-9. PubMed ID: 16600694
[TBL] [Abstract][Full Text] [Related]
16. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
Berthou L; Duverger N; Emmanuel F; Langouët S; Auwerx J; Guillouzo A; Fruchart JC; Rubin E; Denèfle P; Staels B; Branellec D
J Clin Invest; 1996 Jun; 97(11):2408-16. PubMed ID: 8647932
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages.
Souissi IJ; Billiet L; Cuaz-Pérolin C; Slimane MN; Rouis M
Exp Cell Res; 2008 Nov; 314(18):3405-14. PubMed ID: 18823978
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by fibrates of plasminogen activator inhibitor type-1 expression in human adipocytes and preadipocytes.
Zirlik A; Ernst S; Leugers A; Willecke F; Sobel BE; Bode C; Nordt TK
Thromb Haemost; 2009 Jun; 101(6):1060-9. PubMed ID: 19492148
[TBL] [Abstract][Full Text] [Related]
19. The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes.
Mazzucotelli A; Viguerie N; Tiraby C; Annicotte JS; Mairal A; Klimcakova E; Lepin E; Delmar P; Dejean S; Tavernier G; Lefort C; Hidalgo J; Pineau T; Fajas L; Clément K; Langin D
Diabetes; 2007 Oct; 56(10):2467-75. PubMed ID: 17646210
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
